Cargando…

Inflammatory Biomarkers for Outcome Prediction in Patients With Metastatic Testicular Cancer

Germ cell tumors are the most common malignant tumors in male young adults. Platinum-based chemotherapy has dramatically improved the outcome of metastatic germ cell tumor patients and overall cure rates now exceed 80%. The choice of medical treatment can be guided by the prognosis estimation which...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bleve, Sara, Cursano, Maria Concetta, Casadei, Chiara, Schepisi, Giuseppe, Menna, Cecilia, Urbini, Milena, Gianni, Caterina, De Padova, Silvia, Filograna, Alessia, Gallà, Valentina, Rosti, Giovanni, Barone, Domenico, Chovanec, Michal, Mego, Michal, De Giorgi, Ugo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226315/ https://www.ncbi.nlm.nih.gov/pubmed/35756636 http://dx.doi.org/10.3389/fonc.2022.910087

Ejemplares similares

Vitamin D Deficiency in Testicular Cancer Survivors: A Systematic Review
por: Schepisi, Giuseppe, et al.
Publicado: (2021)

Immune checkpoint inhibitors and Chimeric Antigen Receptor (CAR)-T cell therapy: Potential treatment options against Testicular Germ Cell Tumors
por: Schepisi, Giuseppe, et al.
Publicado: (2023)

Caregiver Emotional Burden in Testicular Cancer Patients: From Patient to Caregiver Support
por: De Padova, Silvia, et al.
Publicado: (2019)

Prognostic Role of Systemic Inflammatory Indexes in Germ Cell Tumors Treated With High-Dose Chemotherapy
por: Cursano, Maria Concetta, et al.
Publicado: (2020)

Primary Mediastinal and Testicular Germ Cell Tumors in Adolescents and Adults: A Comparison of Genomic Alterations and Clinical Implications
por: Urbini, Milena, et al.
Publicado: (2021)

Severe Complications in Testicular Germ Cell Tumors: The Choriocarcinoma Syndrome
por: Rejlekova, Katarina, et al.
Publicado: (2019)

Immunosenescence in Testicular Cancer Survivors: Potential Implications of Cancer Therapies and Psychological Distress
por: De Padova, Silvia, et al.
Publicado: (2021)

Psychosocial Issues in Long-Term Survivors of Testicular Cancer
por: Schepisi, Giuseppe, et al.
Publicado: (2019)

Immune-Related Concepts in Biology and Treatment of Germ-Cell Tumors
por: Chovanec, Michal, et al.
Publicado: (2018)

Vitamin D status among long-term survivors of testicular cancer
por: Schepisi, Giuseppe, et al.
Publicado: (2016)

Immunotherapy in Testicular Germ Cell Tumors
por: Kalavska, Katarina, et al.
Publicado: (2020)

Emerging Prognostic Biomarkers in Testicular Germ Cell Tumors: Looking Beyond Established Practice
por: Chovanec, Michal, et al.
Publicado: (2018)

Glycan Analysis as Biomarkers for Testicular Cancer
por: Hires, Michal, et al.
Publicado: (2019)

The New Frontier of Immunotherapy: Chimeric Antigen Receptor T (CAR-T) Cell and Macrophage (CAR-M) Therapy against Breast Cancer
por: Schepisi, Giuseppe, et al.
Publicado: (2023)

Transient effects of chemotherapy for testicular cancer on mouse behaviour
por: Borbélyová, Veronika, et al.
Publicado: (2020)

Intricacies of Radiographic Assessment in Testicular Germ Cell Tumors
por: Makovník, Marek, et al.
Publicado: (2021)

Circulating inflammatory cells in patients with metastatic breast cancer: Implications for treatment
por: Gianni, Caterina, et al.
Publicado: (2022)

Potential Application of Chimeric Antigen Receptor (CAR)-T Cell Therapy in Renal Cell Tumors
por: Schepisi, Giuseppe, et al.
Publicado: (2020)

Targeted therapies for advanced bladder cancer: new strategies with FGFR inhibitors
por: Casadei, Chiara, et al.
Publicado: (2019)

CAR-T cell therapy: a potential new strategy against prostate cancer
por: Schepisi, Giuseppe, et al.
Publicado: (2019)

Habitual physical activity modulates cardiometabolic health in long-term testicular cancer survivors
por: Amiri, Ali, et al.
Publicado: (2023)

Inflammatory Biomarkers as Predictors of Response to Immunotherapy in Urological Tumors
por: Schepisi, Giuseppe, et al.
Publicado: (2019)

Vitiligo-like lesions in a patient treated with nivolumab for renal cell carcinoma
por: Lolli, Cristian, et al.
Publicado: (2018)

Glycan signatures for the identification of cisplatin‐resistant testicular cancer cell lines: Specific glycoprofiling of human chorionic gonadotropin (hCG)
por: Hires, Michal, et al.
Publicado: (2022)

Potential Impact of Preoperative Circulating Biomarkers on Individual Escalating/de-Escalating Strategies in Early Breast Cancer
por: Gianni, Caterina, et al.
Publicado: (2022)

A Phase II Study of Everolimus Plus Oral Prednisone in Patients with Metastatic Renal Cell Cancer
por: Lolli, Cristian, et al.
Publicado: (2017)

Impact of Somatic DNA Repair Mutations on the Clinical Outcomes of Bone Metastases from Castration-Resistant Prostate Cancer
por: Cursano, Maria Concetta, et al.
Publicado: (2023)

Melphalan as a Promising Treatment for BRCA-Related Ovarian Carcinoma
por: Conteduca, Vincenza, et al.
Publicado: (2021)

Exploring the Potential Role of the Gut Microbiome in Chemotherapy-Induced Neurocognitive Disorders and Cardiovascular Toxicity
por: Ciernikova, Sona, et al.
Publicado: (2021)

Long-Term Cognitive Dysfunction in Cancer Survivors
por: Országhová, Zuzana, et al.
Publicado: (2021)

Are Changes in the Percentage of Specific Leukocyte Subpopulations Associated with Endogenous DNA Damage Levels in Testicular Cancer Patients?
por: Kalavska, Katarina, et al.
Publicado: (2021)

Overcoming Chemotherapy Resistance in Germ Cell Tumors
por: Országhová, Zuzana, et al.
Publicado: (2022)

Impact of Non-Pulmonary Visceral Metastases in the Prognosis and Practice of Metastatic Testicular Germ Cell Tumors
por: Rossi, Lorena, et al.
Publicado: (2016)

The Interplay between Inflammation, Anti-Angiogenic Agents, and Immune Checkpoint Inhibitors: Perspectives for Renal Cell Cancer Treatment
por: Brighi, Nicole, et al.
Publicado: (2019)

Cognitive impairment and biomarkers of gut microbial translocation in testicular germ cell tumor survivors
por: Chovanec, Michal, et al.
Publicado: (2023)

βcatenin is a marker of poor clinical characteristics and suppressed immune infiltration in testicular germ cell tumors
por: Chovanec, Michal, et al.
Publicado: (2018)

Prognostic role of programmed-death ligand 1 (PD-L1) expressing tumor infiltrating lymphocytes in testicular germ cell tumors
por: Chovanec, Michal, et al.
Publicado: (2017)

Immunotherapy for Prostate Cancer: Where We Are Headed
por: Schepisi, Giuseppe, et al.
Publicado: (2017)

Prognostic value of intratumoral carbonic anhydrase IX expression in testicular germ cell tumors
por: Kalavska, Katarina, et al.
Publicado: (2017)

Systemic immune-inflammation index in germ-cell tumours
por: Chovanec, Michal, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_g3iiaaohe17mgj4vm02tj3jgfl